Clinical Effectiveness of Oral Semaglutide in Women with Type 2 Diabetes: A Nationwide, Multicentre, Retrospective, Observational Study (Women_ENDO2S-RWD Substudy).

At 6 months, in multivariable analysis, women with a baseline HbA1c ≥ 8% were more likely to reach the primary endpoint [aOR 4.4 (2.1–9.3)] p < 0.001, while those with a BMI ≥ 35 kg/m 2 almost reached statistical significance [adjusted odds ratio, aOR: 2.0 (0.98–4.1)] p = 0.05.

also in 87 other papers